1) Chua ML, Wee JT, Hui EP, Chan AT. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012–1024.
2) Hui EP, Leung SF, Au JS, et al. Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Cancer.
2004;101(2):300–306.
3) Pan CC, Lu J, Yu JR, et al. Challenges in the modification of the M1 stage of the TNM staging
system for nasopharyngeal carcinoma: a study of 1027 cases and review of the literature. Exp Ther Med.
2012;4(2):334–338.
4) Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8–10.
5) Rades D, Dziggel L, Janssen S, Blanck O, Hornung D, Schild SE. A survival score for patients receiving stereotactic radiosurgery alone for brain metastases from breast cancer. Anticancer Res. 2016;36(3):1073–1076.
6) Janssen S, Rades D. Primary breast cancer with synchronous metastatic disease: indications for local
radiotherapy to the breast and chest wall. Anticancer Res. 2015;35(11):5807–5812.
7) Pasqualetti F, Montrone S, Vivaldi C, et al. Stereotactic body radiotherapy in patients with lung oligometastases from colorectal cancer. Anticancer Res. 2017;37(1):315–319.
8) Niibe Y, Yamashita H, Sekiguchi K, et al. Stereotactic body radiotherapy results for pulmonary oligometastases: a two-institution collaborative investigation. Anticancer Res. 2015;35(9):4903–4908.
9) Palma DA, Louie AV, Rodrigues GB. New strategies in stereotactic radiotherapy for oligometastases. Clin
Cancer Res. 2015;21(23):5198–5204.
10) Planchard D, Soria JC, Michiels S, et al. Uncertain benefit from surgery in patients with lung metastases
from breast carcinoma. Cancer. 2004;100(1):28–35.
11) McDonald ML, Deschamps C, Ilstrup DM, Allen MS, Trastek VF, Pairolero PC. Pulmonary resection for
metastatic breast cancer. Ann Thorac Surg. 1994;58(6):1599–1602.
12) Tian YH, Zou WH, Xiao WW, et al. Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: a
subset with better overall survival. Head Neck. 2016;38(8):1152–1157.
13) Cheuk DK, Billups CA, Martin MG, et al. Prognostic factors and long-term outcomes of childhood
nasopharyngeal carcinoma. Cancer. 2011;117(1):197–206.
14) Mertens R, Granzen B, Lassay L, Gademann G, Hess CF, Heimann G. Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft
fur Padiatrische Onkologie und Hamatologie. Cancer. 1997;80(5):951–959.
15) Zubizarreta PA, D’Antonio G, Raslawski E, et al. Nasopharyngeal carcinoma in childhood and adolescence:
a single-institution experience with combined therapy. Cancer. 2000;89(3):690–695.
16) Richards MK, Dahl JP, Gow K, et al. Factors Associated with mortality in pediatric vs adult nasopharyngeal
carcinoma. JAMA Otolaryngol Head Neck Surg. 2016;142(3):217–222.
17) Chan OS, Ngan RK. Individualized treatment in stage IVC nasopharyngeal carcinoma. Oral Oncol.
2014;50(9):791–797.
18) Ou SH, Zell JA, Ziogas A, Anton-Culver H. Epidemiology of nasopharyngeal carcinoma in the United
States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology.
Ann Oncol. 2007;18(1):29–35.
19) Reddy SP, Raslan WF, Gooneratne S, Kathuria S, Marks JE. Prognostic significance of keratinization in
nasopharyngeal carcinoma. Am J Otolaryngol. 1995;16(2):103–108.
20) Onishi H, Ozaki M, Kuriyama K, et al. Stereotactic body radiotherapy for metachronous multisite oligorecurrence: a long-surviving case with sequential oligo-recurrence in four different organs treated using
locally radical radiotherapy and a review of the literature. Pulm Med. 2012;2012:713073.
21) Withers HR, Lee SP. Modeling growth kinetics and statistical distribution of oligometastases. Semin Radiat
Oncol. 2006;16(2):111–119.
22) Formenti SC, Demaria S. Systemic effects of local radiotherapy. Lancet Oncol. 2009;10(7):718–726.
23) Ahmed MM, Guha C, Hodge JW, Jaffee E. Immunobiology of radiotherapy: new paradigms. Radiat Res.
2014;182(2):123–125.
...
論文の公開元へ
